Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Park Plaza
Suite 1750
Irvine, CA 92614Phone+1 949-538-2289
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1990 - 1995
- Rush University Medical CenterResidency, Pediatrics, 1987 - 1990
- McGaw Medical Center of Northwestern UniversityFellowship, Neurology, 1984 - 1987
- Kyung Hee University College of MedicineClass of 1983, MD
Certifications & Licensure
- CA State Medical License 1993 - 2025
- MD State Medical License 2003 - 2003
- IL State Medical License 1988 - 1993
- American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- 99 citationsSafety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies...Joseph M. Parker, Chad K. Oh, Craig LaForce, S. David Miller, David S. Pearlman
BMC Pulmonary Medicine. 2011-02-28 - 190 citationsInvestigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma.Chad K. Oh, Gregory P. Geba, Nestor A. Molfino
European Respiratory Review. 2010-03-01 - 62 citationsHypoxia-induced HIF-1 α accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: Involvement of ERK1/2 and PI-3K/AktQunzhou Zhang, Chad K. Oh, Diana V. Messadi, Hai S. Duong, A. Paul Kelly
Experimental Cell Research. 2006-01-15
Press Mentions
- Image-Guided Superficial Radiotherapy Is 99.3 Percent Effective in Treating Common Skin Cancers Without Surgery, Study SuggestsSeptember 10th, 2021
- AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development of ABP-450 Across Several Therapeutic IndicationsJune 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: